Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 44851-44900 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT05919342
"Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY SYMPHONY-HF"
NA
Recruiting
3,904 participants
Started: Dec 22, 2022 · Completed: Dec 21, 2032
2 conditions
13 sponsors
7 locations
NCT05611892
Biodistribution and Pathophysiology Study of 18F-Fluorodeoxysorbitol (18F-FDS) in Diseased Patients
N/A
Recruiting
30 participants
Started: Dec 22, 2022 · Completed: May 31, 2027
4 conditions
2 sponsors
1 location
NCT05313165
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
NA
Recruiting
100 participants
Started: Dec 22, 2022 · Completed: May 1, 2027
3 conditions
1 sponsor
30 locations
NCT05412290
Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell Lymphoma
PHASE1
Recruiting
15 participants
Started: Dec 22, 2022 · Completed: Aug 31, 2028
6 conditions
2 sponsors
1 location
NCT05653388
Metastatic Leiomyosarcoma Biomarker Protocol
N/A
Recruiting
200 participants
Started: Dec 22, 2022 · Completed: Dec 31, 2026
1 condition
2 sponsors
10 locations
NCT06289660
Multicenter Italian Cohort Study on Tuberculosis in Pediatric Age
N/A
Recruiting
1,000 participants
Started: Dec 22, 2022 · Completed: Mar 1, 2033
1 condition
1 sponsor
17 locations
NCT06466902
Evaluation of Intra-operative Photographs for the Assessment of a Proper Lymphadenectomy in Minimally-invasive Gastrectomies for Gastric Cancer (PhotoNodes)
N/A
Recruiting
326 participants
Started: Dec 22, 2022 · Completed: Dec 31, 2027
10 conditions
1 sponsor
8 locations
NCT05757336
Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer
PHASE2
Recruiting
50 participants
Started: Dec 22, 2022 · Completed: Dec 22, 2026
3 conditions
1 sponsor
1 location
NCT05419960
Audio-vestibular Evaluation of Children and Young Adults With Osteogenesis Imperfecta
N/A
Recruiting
44 participants
Started: Dec 22, 2022 · Completed: Dec 22, 2027
1 condition
2 sponsors
1 location
NCT05527548
A Single-blind RCT to Investigate the Effect of Alendronate on Knee Function Following ACLR
PHASE4
Recruiting
64 participants
Started: Dec 22, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06237803
European Myeloma Network (EMN) Sample Project
N/A
Recruiting
6,000 participants
Started: Dec 21, 2022 · Completed: Dec 31, 2037
5 conditions
2 sponsors
30 locations
NCT05950750
Turkey Thrombotic Thrombocytopenic Purpura Disease Registry: National Multicenter Study
N/A
Recruiting
960 participants
Started: Dec 21, 2022 · Completed: Dec 21, 2026
1 condition
2 sponsors
1 location
NCT05862103
Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort
N/A
Recruiting
15,000 participants
Started: Dec 21, 2022 · Completed: Dec 30, 2026
2 conditions
1 sponsor
18 locations
NCT06188598
Time-restricted Eating in Peri- and Postmenopausal Women
NA
Recruiting
100 participants
Started: Dec 21, 2022 · Completed: Dec 21, 2024
3 conditions
1 sponsor
1 location
NCT05694884
Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab
PHASE2
Recruiting
75 participants
Started: Dec 21, 2022 · Completed: Feb 28, 2025
1 condition
1 sponsor
27 locations
NCT05488548
Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies
PHASE1
Recruiting
75 participants
Started: Dec 21, 2022 · Completed: May 31, 2025
4 conditions
1 sponsor
6 locations
NCT05633810
COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes
PHASE3
Recruiting
10,000 participants
Started: Dec 21, 2022 · Completed: Dec 31, 2027
2 conditions
1 sponsor
1 location
NCT06806579
Atezolizumab-bevacizumab and Other Immunotherapies: Real-life Experience for Treatment of Hepatocellular Carcinoma
N/A
Recruiting
1,000 participants
Started: Dec 21, 2022 · Completed: Oct 31, 2031
1 condition
1 sponsor
24 locations
NCT05880914
Precision Medicine Approaches to Renal Osteodystrophy
N/A
Recruiting
40 participants
Started: Dec 21, 2022 · Completed: Jun 30, 2027
5 conditions
3 sponsors
1 location
NCT05161169
Implementation of Whole Genome Sequencing as Screening in a Diverse Cohort of Healthy Infants
NA
Recruiting
500 participants
Started: Dec 21, 2022 · Completed: Jul 1, 2025
2 conditions
13 sponsors
4 locations
NCT06727383
CAR-NK Cells Production and Expansion From Patients With Lympho or Myeloproliferative Disorders and From Healthy Donors
NA
Recruiting
140 participants
Started: Dec 21, 2022 · Completed: Dec 21, 2025
3 conditions
1 sponsor
1 location
NCT05525507
Retro-active Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-identical Kidney Transplants
PHASE1
Recruiting
10 participants
Started: Dec 21, 2022 · Completed: Sep 30, 2026
4 conditions
1 sponsor
1 location
NCT05525247
A Phase 1/2, Open-label, Multicenter, Dose Escalation and Expansion Study of SLC-3010 Monotherapy and in Combination
PHASE1/PHASE2
Recruiting
420 participants
Started: Dec 21, 2022 · Completed: Jan 31, 2028
1 condition
1 sponsor
9 locations
NCT05530317
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
NA
Recruiting
20 participants
Started: Dec 21, 2022 · Completed: Sep 30, 2025
2 conditions
1 sponsor
1 location
NCT05711888
Semantic Recognition Task (SRT) in Alzheimer Disease
NA
Recruiting
80 participants
Started: Dec 21, 2022 · Completed: Dec 26, 2027
1 condition
1 sponsor
1 location
NCT05681689
PyloPlus Urea Breath Test System Post Therapy Efficacy Confirmation Study
PHASE3
Recruiting
77 participants
Started: Dec 21, 2022 · Completed: Jun 30, 2023
3 conditions
1 sponsor
2 locations
NCT05674825
Investigation of Profile-related Evidence Determining Individualized Cancer Therapy for Patients With Aggressive Malignancies and Poor Prognoses
PHASE1/PHASE2
Recruiting
400 participants
Started: Dec 21, 2022 · Completed: Jan 31, 2031
1 condition
1 sponsor
1 location
NCT05376878
An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis
PHASE4
Recruiting
10 participants
Started: Dec 21, 2022 · Completed: Feb 25, 2026
3 conditions
2 sponsors
1 location
NCT05190094
Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies.
PHASE2
Recruiting
80 participants
Started: Dec 20, 2022 · Completed: Jun 30, 2026
1 condition
4 sponsors
7 locations
NCT05679206
Antiphospholipid Syndrome and Postpartum Pulmonary Artery Pressure
N/A
Recruiting
900 participants
Started: Dec 20, 2022 · Completed: Dec 31, 2028
3 conditions
1 sponsor
1 location
NCT05767216
Genetic and Epigenetic Variations in Heterokaryotypic Monozygotic Twins Discordant for Down Syndrome
NA
Recruiting
5 participants
Started: Dec 20, 2022 · Completed: Dec 30, 2028
1 condition
1 sponsor
1 location
NCT05490472
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
PHASE1/PHASE2
Recruiting
102 participants
Started: Dec 20, 2022 · Completed: Aug 31, 2026
5 conditions
1 sponsor
5 locations
NCT05723718
MalnutritiOn Assessment With biOelectrical impedaNce Analysis in gastRic Cancer patIentS Undergoing Multimodal trEatment
N/A
Recruiting
125 participants
Started: Dec 20, 2022 · Completed: Dec 31, 2028
4 conditions
5 sponsors
1 location
NCT05346627
Home Based Personalized Training and Video Consultation in Mitochondrial Myopathies: Study of Efficacy and Tolerance.
NA
Recruiting
15 participants
Started: Dec 20, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05984875
The Immune Landscape of Epithelial Ovarian Cancer
N/A
Recruiting
74 participants
Started: Dec 20, 2022 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT05378399
SmartSteps: A Context-Aware, PrEP Adherence Intervention for Individuals With Substance Use Disorder
PHASE3
Recruiting
40 participants
Started: Dec 20, 2022 · Completed: Mar 31, 2026
4 conditions
3 sponsors
1 location
NCT06211062
The Use of Directed Probiotics in ME/CFS: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
PHASE2
Recruiting
100 participants
Started: Dec 20, 2022 · Completed: Feb 24, 2026
2 conditions
1 sponsor
1 location
NCT04935684
Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
PHASE2
Recruiting
150 participants
Started: Dec 20, 2022 · Completed: Dec 31, 2027
7 conditions
3 sponsors
20 locations
NCT05456412
JAK Inhibition in Ulcerative Colitis
NA
Recruiting
60 participants
Started: Dec 20, 2022 · Completed: Sep 30, 2026
1 condition
2 sponsors
1 location
NCT05653453
Clinical Study of Tumor Treating Fields Combined with Gemcitabine and Albumin-bound Paclitaxel in the First-line Treatment of Locally Advanced Pancreatic Cancer
PHASE3
Recruiting
512 participants
Started: Dec 20, 2022 · Completed: Sep 28, 2027
1 condition
1 sponsor
5 locations
NCT05704335
InfluenCEF Study: Study on the Headache Associated With Influenza Infection
N/A
Recruiting
100 participants
Started: Dec 20, 2022 · Completed: Nov 30, 2024
5 conditions
4 sponsors
1 location
NCT05099874
Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease
NA
Recruiting
20 participants
Started: Dec 20, 2022 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT05657678
Vitamin D3 Supplementation in Critically Ill Patients Undergoing CRRT
PHASE4
Recruiting
138 participants
Started: Dec 20, 2022 · Completed: May 1, 2026
1 condition
1 sponsor
4 locations
NCT05683379
AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Boys With DMD
N/A
Recruiting
200 participants
Started: Dec 20, 2022 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT05637086
Clinical Study Evaluating Safety of Pentoxifylline and Celecoxib in Patients With Grand-Mal Epilepsy Treated by Phenytoin Monotherapy
PHASE2
Recruiting
90 participants
Started: Dec 20, 2022 · Completed: Nov 20, 2027
1 condition
3 sponsors
1 location
NCT05487599
A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)
PHASE1/PHASE2
Recruiting
15 participants
Started: Dec 20, 2022 · Completed: Oct 2, 2030
2 conditions
2 sponsors
8 locations
NCT06114940
Perioperative TORIPALIMAB Plus LENVATINIB in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PLUTO)
PHASE2
Recruiting
69 participants
Started: Dec 20, 2022 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT05475678
Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer
PHASE2
Recruiting
369 participants
Started: Dec 20, 2022 · Completed: Dec 31, 2029
3 conditions
1 sponsor
1 location
NCT05716997
Relationship Between Coronary Angiography Findings and Fractional Flow Reserve After Balloon Angioplasty
N/A
Recruiting
100 participants
Started: Dec 20, 2022 · Completed: Dec 31, 2026
1 condition
2 sponsors
2 locations
NCT05751798
Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas
PHASE1/PHASE2
Recruiting
41 participants
Started: Dec 20, 2022 · Completed: Dec 31, 2029
3 conditions
1 sponsor
10 locations
Previous
1
More pages
895
896
897
898
899
900
901
More pages
1333
Next